Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald C DeConti

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2008
Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factorAdil I Daud, Noweeda Mirza, Brianna Lenox, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2008
Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanomaAdil I Daud, Ronald C DeConti, Stephanie Andrews, et al.
American Journal of Clinical Oncology|December 19, 2009
A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331)Wolfram E Samlowski, James Moon, Ralph J Tuthill, et al.
Annals of Surgical Oncology|October 12, 2017
Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma MetastasesMark B Faries, Nicola Mozzillo, Mohammed Kashani-Sabet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2014
Safety, correlative markers, and clinical results of adjuvant nivolumab in combination with vaccine in resected high-risk metastatic melanomaGeoffrey T Gibney, Ragini R Kudchadkar, Ronald C DeConti, et al.
Cancer|June 4, 2015
Both tumor depth and diameter are predictive of sentinel lymph node status and survival in Merkel cell carcinomaFranz O Smith, Binglin Yue, Suroosh S Marzban, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2007
Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous melanomaMalcolm S Mitchell, Judith Abrams, John A Thompson, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2008
Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factorAdil I Daud, Noweeda Mirza, Brianna Lenox, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2008
Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanomaAdil I Daud, Ronald C DeConti, Stephanie Andrews, et al.
American Journal of Clinical Oncology|December 19, 2009
A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331)Wolfram E Samlowski, James Moon, Ralph J Tuthill, et al.
Annals of Surgical Oncology|October 12, 2017
Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma MetastasesMark B Faries, Nicola Mozzillo, Mohammed Kashani-Sabet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2014
Safety, correlative markers, and clinical results of adjuvant nivolumab in combination with vaccine in resected high-risk metastatic melanomaGeoffrey T Gibney, Ragini R Kudchadkar, Ronald C DeConti, et al.
Cancer|June 4, 2015
Both tumor depth and diameter are predictive of sentinel lymph node status and survival in Merkel cell carcinomaFranz O Smith, Binglin Yue, Suroosh S Marzban, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2007
Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous melanomaMalcolm S Mitchell, Judith Abrams, John A Thompson, et al.
Pageof 2